FDA Grants Pemivibart Emergency Use Authorization for PrEP of COVID-19 in Immunocompromised Patients

The indication is for adults and adolescents with moderate to severe immune compromise due to medical conditions or immunosuppressive medications and treatments.

Related Keywords

Cameronr Wolfe ,Dave Hering ,Deficiency Foundation ,Duke University School Of Medicine ,Invivyd Inc ,Adults With Immune Compromise ,Participants Aged ,Older Who Are ,Duke University School ,Jorey Berry ,Immune Deficiency Foundation ,Immunocompromised Collaborative ,